Kolkhir P, Fok J, Kocaturk E, Li P, Okas T, Marcelino J
Drugs. 2025; .
PMID: 40074986
DOI: 10.1007/s40265-025-02170-4.
Castells M, Madden M, Oskeritzian C
Curr Allergy Asthma Rep. 2024; 25(1):5.
PMID: 39585499
PMC: 11588779.
DOI: 10.1007/s11882-024-01183-5.
Kumar M, Choi Y, Wong T, Li P, Chow B
J Eur Acad Dermatol Venereol. 2024; 39(3):476-486.
PMID: 39044547
PMC: 11851267.
DOI: 10.1111/jdv.20249.
Villanueva C, Barksdale K, Owolabi T, Bridges D, Chichester K, Saini S
Front Allergy. 2024; 5:1373511.
PMID: 38601026
PMC: 11004268.
DOI: 10.3389/falgy.2024.1373511.
Alvarez-Arango S, Kumar M, Chow T, Sabato V
J Allergy Clin Immunol Pract. 2024; 12(5):1109-1119.
PMID: 38423288
PMC: 11081849.
DOI: 10.1016/j.jaip.2024.02.019.
Potential Role of Moesin in Regulating Mast Cell Secretion.
Theoharides T, Kempuraj D
Int J Mol Sci. 2023; 24(15).
PMID: 37569454
PMC: 10418457.
DOI: 10.3390/ijms241512081.
Mas-related G protein-coupled receptor MRGPRX2 in human basophils: Expression and functional studies.
Toscano A, Elst J, Van Gasse A, Beyens M, van der Poorten M, Bridts C
Front Immunol. 2023; 13:1026304.
PMID: 36726977
PMC: 9885256.
DOI: 10.3389/fimmu.2022.1026304.
Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist.
Bawazir M, Amponnawarat A, Hui Y, Oskeritzian C, Ali H
Front Immunol. 2022; 13:1033794.
PMID: 36275683
PMC: 9582160.
DOI: 10.3389/fimmu.2022.1033794.
MRGPRX2 in drug allergy: What we know and what we do not know.
Kolkhir P, Ali H, Babina M, Ebo D, Sabato V, Elst J
J Allergy Clin Immunol. 2022; 151(2):410-412.
PMID: 36089079
PMC: 9905269.
DOI: 10.1016/j.jaci.2022.09.004.
The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity.
Pyatilova P, Ashry T, Luo Y, He J, Bonnekoh H, Jiao Q
Front Immunol. 2022; 13:930945.
PMID: 35958589
PMC: 9361751.
DOI: 10.3389/fimmu.2022.930945.
β-arrestin-1 and β-arrestin-2 Restrain MRGPRX2-Triggered Degranulation and ERK1/2 Activation in Human Skin Mast Cells.
Wang Z, Li Z, Bal G, Franke K, Zuberbier T, Babina M
Front Allergy. 2022; 3:930233.
PMID: 35910860
PMC: 9337275.
DOI: 10.3389/falgy.2022.930233.
MRGPRX2-Mediated Degranulation of Human Skin Mast Cells Requires the Operation of G, G, Ca++ Channels, ERK1/2 and PI3K-Interconnection between Early and Late Signaling.
Wang Z, Franke K, Bal G, Li Z, Zuberbier T, Babina M
Cells. 2022; 11(6).
PMID: 35326404
PMC: 8946553.
DOI: 10.3390/cells11060953.